Skip to main content

Table 2 Care received at outlet and patient status at interview by sector (%, 95% CI)

From: Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy?

 

Public health facilities (N = 572 patients from 40 outlets)

Private ADDOs (N = 450 patients from 37 outlets)

p-value

Treatment received at outlet

   

Tested for malaria

54.4 (40.3, 67.9)

11.1 (8.0, 15.4)

<0.0001

Told diagnosis

64.1 (56.3, 71.1)

53.5 (46.1, 60.8)

0.051

Obtained correct blister pack for age1

78.9 (74.7, 82.5)

83.1 (78.7, 86.8)

0.1

Paid for AL

28.7 (24.0, 34.0)

97.8 (96.1, 98.7)

<0.0001

Took first dose of AL at outlet

40.7 (29.8, 52.7)

9.6 (6.3, 14.2)

<0.0001

Recall of instructions received from dispenser

   

Recalled correct instructions given by dispenser on the number of pills per dose, number of doses, and number of days to take AL

60.8 (56.4, 65.2)

59.3 (53.7, 64.7)

0.7

Recalled that dispenser used packaging as a visual aid to explain how to take AL

85.6 (81.9, 88.6)

82.9 (77.9, 86.9)

0.3

Reported being told to take the second dose of AL eight hours after the first dose

58.0 (51.3, 64.5)

63.3 (57.9, 68.4)

0.2

Reported being told to take AL with food or milk

63.8 (57.9, 69.3)

61.8 (54.6, 68.5)

0.7

Reported being told to complete all doses of AL even if feeling better

77.9 (73.5, 81.7)

63.3 (55.7, 70.4)

0.0006

Reported being told to take a replacement dose in case of vomiting within half hour of taking a dose

1.9 (1.1, 3.5)

2.4 (1.3, 4.6)

0.6

Reported being told about possible side effects

2.3 (1.3, 4.0)

3.0 (1.6, 5.6)

0.6

Health status at interview

   

Reported current fever at time of interview

13.7 (10.5, 17.7)

14.7 (11.1, 19.1)

0.7

Could play or work at time of interview

92.6 (89.2, 95.1)

92.4 (89.7, 94.5)

0.9

Tested positive by mRDT at interview2

49.6 (39.7, 59.5)

27.9 (20.7, 36.6)

0.001

Tested positive by blood smear collected at interview3

2.9 (1.7, 4.7)

1.4 (0.6, 3.0)

0.1

Adherence to AL

   

Adherent by ‘verified completed treatment’4

74.6 (69.8, 78.8)

69.8 (64.6, 74.5)

0.2

Adherent by ‘verified timely completion’5

46.0 (40.9, 51.2)

34.8 (30.1, 39.8)

0.003

  1. 1Age categories based on recommended age breakdown for AL blister packs in Tanzania.
  2. 2mRDT data missing for 7 public health facility patients and 17 ADDO patients.
  3. 3Blood smear data missing for 15 public health facility patients and 18 ADDO patients.
  4. 4Patient completed all doses, verified by pill count when available. Data missing for 2 public health facility patients and 3 ADDO patients.
  5. 5Patient completed each dose at correct time with the correct number of pills per dose, verified by pill count when available. Data missing for 13 public health facility patients and 10 ADDO patients.